Source: ERJ Open Res, 4 (4) 00084-2018; 10.1183/23120541.00084-2018
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Vincent Cottin, Dirk Koschel, Andreas Günther, Carlo Albera, Arata Azuma, C. Magnus Sköld, Sara Tomassetti, Philip Hormel, John L. Stauffer, Indiana Strombom, Klaus-Uwe Kirchgaessler, Toby M. Maher. Long-term safety of pirfenidone: results of the prospective, observational PASSPORT study. ERJ Open Res, 4 (4) 00084-2018; 10.1183/23120541.00084-2018

Member's Comments

No comment yet.

Related content which might interest you: Late Breaking Abstract - Long-term safety of pirfenidone in a real-world setting: final results from the prospective, observational PASSPORT registry Source: International Congress 2017 – Late-breaking findings in pulmonary diseases Year: 2017 Efficacy and safety of nintedanib in a Greek multicentre idiopathic pulmonary fibrosis registry: a retrospective, observational, cohort study Source: ERJ Open Res, 6 (1) 00172-2019; 10.1183/23120541.00172-2019 Year: 2020 Benefits of pulmonary rehabilitation in COVID-19 – a prospective observational cohort study Source: Virtual Congress 2021 – Insights into rehabilitation and physiotherapy in COVID-19 Year: 2021 Effectiveness of treatments for severe sepsis: a prospective multicentre observational study in Spanish ICUs Source: Annual Congress 2009 - Severe sepsis and multiple organ failure Year: 2009 The evaluation of the efficacy and safety of phospholipids‘ inhalation in patients with bronchial asthma (BA): A prospective randomized placebo-controlled study Source: Annual Congress 2012 - Asthma treatment: efficacy and safety Year: 2012 REALizing and improving management of COPD in China: A prospective observational study Source: Virtual Congress 2021 – Inhaled treatments for COPD: real-world data Year: 2021 Tiotropium discontinuation in patients with early-stage COPD: a prospective observational cohort study Source: ERJ Open Res, 5 (1) 00175-2018; 10.1183/23120541.00175-2018 Year: 2019 Comparison of Interferon gamma-1b (IFN-γ)and colcicine in the treatment of Idiopathic pulmonary fibrosis: preliminary results of a prospective, multicenter randomised study Source: Eur Respir J 2002; 20: Suppl. 38, 599s Year: 2002 Augmentation therapy for α1-antitrypsin deficiency: a meta-analysis of randomized and non-randomized clinical studies Source: Eur Respir J 2005; 26: Suppl. 49, 288s Year: 2005 Psychiatric complications of COVID-19 pneumonia: preliminary results of a single-centre prospective study. Source: Virtual Congress 2021 – COVID - 19 Year: 2021 Efficacy and costs of telehealth for the management of COPD: PROMETE II, a multicentre, randomized controlled trial Source: International Congress 2017 – New trends in pulmonary rehabilitation and chronic care Year: 2017 COVID-19 pneumothorax in the UK: a prospective observational study using the ISARIC WHO clinical characterisation protocol Source: Eur Respir J, 58 (3) 2100929; 10.1183/13993003.00929-2021 Year: 2021 Clinical, radiological and functional outcomes in patients with COVID-19 pneumonia: A prospective observational study Source: Virtual Congress 2021 – Imaging in COVID-19 Year: 2021 Eszopiclone improves the quality of polysomnography: prospective, blinded, placebo-controlled trial Source: Annual Congress 2008 - Assessment of sleep apnoea Year: 2008 Economic impact of IPF exacerbations in Spain: prospective, observational, multicentric study (OASIS study) Source: Virtual Congress 2021 – Interstitial lung disease around the world Year: 2021 RCT Abstract - Using a smartphone application in COPD patients to increase physical activity following pulmonary rehabilitation. Results of the AMOPUR Study, a multicenter, randomized, controlled study Source: Virtual Congress 2021 – A multidisciplinary approach to the management of chronic respiratory diseases Year: 2021 Characteristics and clinical management of IPF patients in Spain: prospective, observational, multicentric study (OASIS study). Source: Virtual Congress 2020 – Real life in the field of idiopathic pulmonary fibrosis: treatments and registries Year: 2020 Patient-reported outcome measures after COVID-19: a prospective cohort study Source: Eur Respir J, 56 (5) 2003276; 10.1183/13993003.03276-2020 Year: 2020 Predictors of weaning from helmet CPAP in COVID-19: preliminary results from a retrospective observational study Source: Virtual Congress 2021 – Acute non-invasive respiratory therapies in COVID-19 and beyond Year: 2021